Topic suspended
| Status | Suspended |
| Process | STA pre-2018 |
| ID number | 929 |
Project Team
| Project lead | Michelle Adhemar |
Email enquiries
- If you have any queries please email scopingta@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 September 2018 | Suspended, Topic suspended |
| 11 October 2016 | The Department of Health has asked us to carry out a Single Technology Appraisal (STA) of Dabrafenib with trametinib within its marketing authorisation for treating advanced, metastatic BRAF V600E mutation-positive non-small-cell lung cancer Further information regarding the timelines for this appraisal will be available in due course. |
| 22 July 2016 | Referral |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance